Baseline adiponectin and leptin levels in predicting an increased risk of disease activity in rheumatoid arthritis: A meta-analysis and systematic review

References

• Huang, Q., S. S. Tao, and Y. J. Zhang. 2015. Serum resistin levels in patients with rheumatoid arthritis and systemic lupus erythematosus: a meta-analysis. Clin. Rheumatol. 34: 1713–1720
   PubMed Web of Science ®Google Scholar
• Targońska-Stepniak, B., M. Majdan, and M. Dryglewska. 2008. Leptin serum levels in rheumatoid arthritis patients: relation to disease duration and activity. Rheumatol. Int. 28: 585–591
   PubMed Web of Science ®Google Scholar
• Malottki, K., P. Barton, and A. Tsourapas. 2011. Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis after the failure of a tumor necrosis factor inhibitor: a systematic review and economic evaluation. Health. Technol. Assess. 15: 1–278
   PubMed Web of Science ®Google Scholar
• Walsmith, J., and V. R. Roubeno. 2002. Cachexia in rheumatoid arthritis. Int. J. Cardiol. 85: 89–99
   PubMed Web of Science ®Google Scholar
• Walsmith, J., L. Abad, J. Kehayias, and V. R. Roubeno. 2004. Tumor necrosis factor-alpha production is associated with less body cell mass in women with rheumatoid arthritis. J. Rheumatol. 31: 23–29
   PubMed Web of Science ®Google Scholar
• Giles, J. T., M. Allison, C. O. Bingham3rd, et al. 2009. Adiponectin is a mediator of the inverse association of adiposity with radiographic damage in rheumatoid arthritis. Arthritis. Rheum. 61: 1248–1256
   PubMed Web of Science ®Google Scholar
• Smolen, J. S., D. Aletaha, M. Koeller, et al. 2007. New therapies for treatment of rheumatoid arthritis. Lancet. 370: 1861–1874
   PubMed Web of Science ®Google Scholar
• Firestein, G. S. 2003. Evolving concepts of rheumatoid arthritis. Nature. 42: 356–361
   Web of Science ®Google Scholar
• Arend, W. P. 2001. Physiology of cytokine pathways in rheumatoid arthritis. Arthritis. Rheum. 45: 101–106
   PubMed Web of Science ®Google Scholar
• Yoshino, T., N. Kusunoki, N. Tanaka, et al. 2011. Elevated serum levels of resistin, leptin, and adiponectin are associated with C-reactive protein and also other clinical conditions in rheumatoid arthritis. Intern. Med. 50: 269–275
   PubMed Web of Science ®Google Scholar
• Furst, D. E., Breedveld, F. C., and J. R. Kalden, et al. 2007. Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2007. Ann. Rheum. Dis. 66: iii2–ii22
   PubMed Web of Science ®Google Scholar
• Hochberg, M. C., J. K. Tracy, and R. H. Flores. 2001. “Stepping-up” from methotrexate: a systematic review of randomized placebo controlled trials in patients with rheumatoid arthritis with an incomplete response to methotrexate. Ann. Rheum. Dis. 60: iii51–iii54
   PubMed Web of Science ®Google Scholar
• Bokarewa, M., D. Bokarew, O. Hultgren, and A. Tarkowski. 2003. Leptin consumption in the inflamed joints of patients with rheumatoid arthritis. Ann. Rheum. Dis. 62: 952–956
   PubMed Web of Science ®Google Scholar
• Tong, K. M., D. C. Shieh, C. P. Chen, et al. 2008. Leptin induces IL-8 expression via leptin receptor, IRS-1, PI3K, Akt cascade and promotion of NF-kappaB/p300 binding in human synovial fibroblasts. Cell. Signal. 20: 1478–1488
   PubMed Web of Science ®Google Scholar
• Tian, G., J. N. Liang, Z. Y. Wang, and D. Zhou. 2014. Emerging role of leptin in rheumatoid arthritis. Clin. Exp. Immunol. 177: 557–570
   PubMed Web of Science ®Google Scholar
• Yokota, T., K. Oritani, I. Takahashi, et al. 2000. Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood. 96: 1723–1732
   PubMed Web of Science ®Google Scholar
• Tang, C. H., Y. C. Chiu, T. W. Tan, et al. 2007. Adiponectin enhances IL-6 production in human synovial fibroblast via an AdipoR1 receptor, AMPK, p38, and NF-kappa B pathway. J. Immunol. 179: 5483–5492
   PubMed Web of Science ®Google Scholar
• Kitahara, K., N. Kusunoki, T. Kakiuchi, et al. 2009. Adiponectin stimulates IL-8 production by rheumatoid synovial fibroblasts. Biochem. Biophys. Res. Commun. 378: 218–223
   PubMed Web of Science ®Google Scholar
• Kusunoki, N., K. Kitahara, F. Kojima, et al. 2010. Adiponectin stimulates prostaglandin E(2) production in rheumatoid arthritis synovial fibroblasts. Arthritis. Rheum. 62: 1641–1649
   PubMed Web of Science ®Google Scholar
• Xibillé-Friedmann, D. X., E. Ortiz-Panozo, C. Bustos Rivera-Bahena, et al. 2015. Leptin and adiponectin as predictors of disease activity in rheumatoid arthritis. Clin. Exp. Rheumatol. 33: 471–477
   PubMed Web of Science ®Google Scholar
• Laurberg, T. B., J. Frystyk, T. Ellingsen, et al. 2009. Plasma adiponectin in patients with active, early, and chronic rheumatoid arthritis who are steroid- and disease-modifying antirheumatic drug-naive compared with patients with osteoarthritis and controls. J. Rheumatol. 36: 1885–1891
   PubMed Web of Science ®Google Scholar
• Derdemezis, C. S., T. D. Filippatos, P. V. Voulgari, et al. 2009. Effects of a 6-month infliximab treatment on plasma levels of leptin and adiponectin in patients with rheumatoid arthritis. Fundam. Clin. Pharmacol. 23: 595–600
   PubMed Web of Science ®Google Scholar
• Senolt, L., K. Pavelka, D. Housa, and M. Haluzík. 2006. Increased adiponectin is negatively linked to the local inflammatory process in patients with rheumatoid arthritis. Cytokine. 35: 247–252
   PubMed Web of Science ®Google Scholar
• Wells, G. A., B. Shea, D. O’Connell, and A. Rabello. 2000. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Available at: http://www.ohri.ca/programs/clinical_epidemiology/oxford.htm
   Google Scholar
• van der Heijde, D. 2000. How to read radiographs according to the Sharp/van der Heijde method. J. Rheumatol. 27: 261–263
   PubMed Web of Science ®Google Scholar
• Fransen, J., and P. L. van Riel. 2005. The Disease Activity Score and the EULAR response criteria. Clin. Exp. Rheumatol. 23: S93–S99
   PubMed Web of Science ®Google Scholar
• Sterne, J. A., A. J. Sutton, J. P. Ioannidis, et al. 2011. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ. 343: d4002
   PubMed Web of Science ®Google Scholar
• Meyer, M., J. Sellam, S. Fellahi, et al. 2013. Serum level of adiponectin is a surrogate independent biomarker of radiographic disease progression in early rheumatoid arthritis: results from the ESPOIR cohort. Arthritis. Res. Ther. 15: R210
   PubMed Web of Science ®Google Scholar
• Ebina, K., A. Fukuhara, W. Ando, et al. 2009. Serum adiponectin concentrations correlate with severity of rheumatoid arthritis evaluated by extent of joint destruction. Clin. Rheumatol. 28: 445–451
   PubMed Web of Science ®Google Scholar
• Lee, S. W., M. C. Park, Y. B. Park, and S.K. Lee. 2007. Measurement of the serum leptin level could assist disease activity monitoring in rheumatoid arthritis. Rheumatol. Int. 27: 537–540
   PubMed Web of Science ®Google Scholar
• Gunaydin, R., T. Kaya, A. Atay, et al. 2006. Serum leptin levels in rheumatoid arthritis and relationship with disease activity. South. Med. J. 99: 1078–1083
   PubMed Web of Science ®Google Scholar
• Anders, H. J., M. Rihl, A. Heufelder, et al. 1999. Leptin serum levels are not correlated with disease activity in patients with rheumatoid arthritis. Metab. Clin. Exp. 48: 745–748
   PubMed Web of Science ®Google Scholar
• Otero, M., R. Lago, R. Gomez, et al. 2006. Changes in plasma levels of fat derived hormones adiponectin, leptin, resistin and visfatin inpatients with rheumatoid arthritis. Ann. Rheum. Dis. 65: 1198–1201
   PubMed Web of Science ®Google Scholar
• Schäffler, A., A. Ehling, E. Neumann, et al. 2003. Adipocytokines in synovial fluid. JAMA. 290: 1709–1710
   PubMed Web of Science ®Google Scholar
• Tian, G., J. N. Liang, H. F. Pan, and D. Zhou. 2014. Increased leptin levels in patients with rheumatoid arthritis: a meta-analysis. Ir. J. Med. Sci. 183: 659–666
   PubMed Web of Science ®Google Scholar
• La Cava, A., and G. Matarese. 2004. The weight of leptin in immunity. Nat. Rev. Immunol. 4: 371–379
   PubMed Web of Science ®Google Scholar
• Gertler, A. 2006. Development of leptin antagonists and their potential use in experimental biology and medicine. Trends. Endocrinol. Metab. 17: 372–378
   PubMed Web of Science ®Google Scholar
• Welsing, P. M., R. B. Landewé, P. L. van Riel, et al. 2004. The relationship between disease activity and radiologic progression in patients with rheumatoid arthritis: a longitudinal analysis. Arthritis. Rheum. 50: 2082–2093
   PubMed Web of Science ®Google Scholar
• Chen, C. Y., M. Fujimiya, A. Laviano, et al. 2010. Modulation of ingestive behavior and gastrointestinal motility by ghrelin in diabetic animals and humans. J. Chin. Med. Assoc. 73: 225–229
   PubMed Web of Science ®Google Scholar
• Otero, M., R. Nogueiras, F. Lago, et al. 2004. Chronic inflammation modulates ghrelin levels in humans and rats. Rheumatology (Oxford). 43: 306–310
   PubMed Web of Science ®Google Scholar
• Koca, S. S., M. Ozgen, S. Aydin, et al. 2008. Ghrelin and obestatin levels in rheumatoid arthritis. Inflammation. 31: 329–335
   PubMed Web of Science ®Google Scholar
• Chen, C. Y., C. Y. Tsai, P. C. Lee, and S. D. Lee. 2013. Long-term etanercept therapy favors weight gain and ameliorates cachexia in rheumatoid arthritis patients: roles of gut hormones and leptin. Curr. Pharm. Des. 19: 1956–1964
   PubMed Web of Science ®Google Scholar